GENE ONLINE|News &
BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
Over the last two decades, significant progress has been made in cancer therapeutics, but significant challenges remain. At the BIO CEO and Investor Digital Conference, experts from leading companies discussed key issues such as. how to drive innovation in oncology, spotting the right investment, the future of PD-1 therapies, and emerging game changers in the field.
Driving Innovation in Oncology: Internal vs. External Pipelines
To drive innovation, Eli Lilly is going after compelling science. Its mantra for getting innovative cancer treatment is “going after actionable targets where there is a clear unmet need based on the current standard of care,” says Avnish Kapoor, Director, Emerging Technology and Innovation
Driving Innovation in Oncology: Internal vs. External Pipelines
To drive innovation, Eli Lilly is going after compelling science. Its mantra for getting innovative cancer treatment is “going after actionable targets where there is a clear unmet need based on the current standard of care,” says Avnish Kapoor, Director, Emerging Technology and Innovation
It's free! Log in now to read
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
